Anbieter einloggen
Home
BLEIBEN SIE UPTODATE
Registrieren Sie sich für unseren monatlichen Newsletter.
Ihre Adresse wird nicht an Dritte weitergegeben.
Zu unseren Datenschutz-Bestimmungen.

   

News

Tragen Sie Ihre News ein
News Update: Custom Pharmaceutical Excipients Development Available at Formulationbio
News Update: Custom Pharmaceutical Excipients Development Available
at Formulationbio Known as not only a provider of various excipients but also a CRO for pharmaceutical formulation, Formulationbio announces to provide tailor-made pharmaceutical excipients development service for customers across the globe on April 20, 2021. Excipients play an indispensable role in the manufacture of a drug product. And Formulationbio has long been supplying various excipients for solid, semi-solid and liquid dosage forms, such as binder excipients, disintegrant excipients, sweetener excipients, emulsifier excipients, carrier excipients, and many more. However, the past decade has seen a drastic expansion of the pharmaceutical industry, which generates greater demand for novel excipients. In other words, traditional excipients are difficult to meet the market demand. To create the excipients that are exactly what clients needed, Formulationbio now offers customized services for new pharmaceutical excipient development. “We know that the development of new excipient
27.04.2021  |  014x  |  Kurzbericht  | 
Eight Commonly Used Techniques for Drug Analysis
Eight Commonly Used Techniques for Drug Analysis
Drug analysis refers to the detection and analysis of ingredients and contents in drugs. Drug analysis and testing (formulationbio.com/analytical.html) involves the study of composition, physical and chemical properties, purity, and the determination of the content of active pharmaceutical ingredients and their preparations, to ensure that the medications are safe, rational, and effective. Drug analysis and testing are very important for drug development, which generally encompasses disintegration test, dissolution test, tablet hardness test, tablet fragility test, residual solvents test, dosage units uniformity test, bioavailability/bioequivalence detection, microbial limits test, particulate matter test, elemental impurities analysis formulationbio.com/elemental-impurities-analysis.html), and extractables & leachables test. To accomplish these analytical testing tasks, some drug analysis methods are employed. The most commonly used drug analysis methods are as follows:
27.04.2021  |  013x  |  Fachbeitrag  | 
Formulation Development and Analytical Services at Formulationbio
for the pharmaceutical Industry Formulation development is of paramount importance for new drug development as it can determine patentability, lifecycle and, ultimately, the success of a pharmaceutical product. Fully aware of the challenges that may arise from this process, Formulationbio recently announces that it now provides a comprehensive range of formulation development and analytical services for the pharmaceutical industry. “Pharmaceutical formulation development is an indispensable step that makes the new drug substance being discovered gradually develop into a commercial drug product,” commented a senior scientist from Formulationbio. The scientist responsible for drug formulation must determine the most appropriate administration route to achieving effective drug delivery, and then optimize the formulation’s characteristics while taking into consideration the drug product’s bioavailability and processing requirements. According to statistics, only 10% of new drug products in preclinical
27.04.2021  |  018x  |  Produktnews
MedAI Launches Integrated Drug Discovery Approaches to Solve In Silico Drug Discovery Problems
MedAI Launches Integrated Drug Discovery Approaches
to Solve In Silico Drug Discovery Problems On April 20, 2021, MedAI announces that it has launched integrated drug discovery approaches to help to solve in silico drug discovery challenges, such as problems arising from drug candidate compound screening, target profiling, compound structure scoring in de novo design, and other related calculations. The past decade has seen the bigger role played by artificial intelligence in the different pharmaceutical application scenarios, such as the analysis of small molecules or antibodies. Being able to access industry standard hardware and software, MedAI manages to tap the full potential of compute power and apply it to tackle challenges from computational chemistry, molecular simulations, and chemical informatics so as to accelerate clients’ drug discovery projects. “Our experts who are specialized in computer-aided drug design can work closely with our clients to design experiments and get the results they need to make wise decisions and advance the projects,” commented
24.04.2021  |  019x  |  Produktnews  | 
The application bottleneck, innovation and development of AI in pharmaceutical and chemical fields
The application bottleneck, innovation and development of AI
in pharmaceutical and chemical fields With the birth of computer science in the early 21st century, mankind has entered a new era in terms of information storage. Early algorithms are mainly dedicated to liberating repetitive and tedious mathematical and logical operations. But in the following decades, the theoretical basis of related machine learning and various algorithms have been developed by leaps and bounds. Now the organic combination of big data, algorithms and computing power has contributed the application of artificial intelligence in many fields. Chemistry is a classic discipline of natural sciences, which aims to study the composition, properties, structure and changing laws of matter at the molecular and atomic levels. Chemistry is closely related to human production and life, and plays a vital role in energy, materials, pharmaceuticals and other fields. Traditional chemical research and chemical production rely heavily on experiments guided by theory, requiring a lot of manpower and material
24.04.2021  |  019x  |  Fachbeitrag  | 
News Update: MedAI Integrates Three Platform AIDD Platform, CADD Platform, and Experimental Validation Platform for Drug Discovery
News Update: MedAI Integrates Three Platform
AIDD Platform, CADD Platform, and Experimental Validation Platform for Drug Discovery Earlier this month, MedAI announces that it has integrated its three AI-powered drug discovery platforms so as to increase drug candidate efficacy and safety throughout the preclinical research. Previously, the company has released AIDD Platform, CADD Platform, and Experimental Validation Platform, which consist of proprietary hardware, biological, molecular and digital technologies. “The indispensable role of data analytics, knowledge management and artificial intelligence in early drug discovery has been approved in the past few years. We are looking forward to partnering with large pharmaceutical companies to co-develop drug R&D projects,” commented a senior scientist from MedAI. The three drug discovery platforms built by MedAI are: AIDD Platform Artificial Intelligence Drug Discovery (AIDD) platform is constructed for the purpose of addressing two of the key bottlenecks in drug discovery: first, previously intractable therapeutic targets may become amenable to
24.04.2021  |  012x  |  Kurzbericht  | 
Folgende 6 Berichte
ARCHIV
MAXUS MEDIA
LABinsights.net LABinsights.de LABinsights.nl
Erhalten Sie unseren Newsletter
Newsletter Archiv
SERVICE UND KONTAKT flag